Impact of rifampicin dose in bone and joint prosthetic device infections due to Staphylococcus spp: a retrospective single-center study in France

BACKGROUND: Prosthetic joint infections (PJI) are a major cause of morbidity and mortality burden worldwide. While surgical management is well defined, rifampicin (RIF) dose remains controversial. The aim of our study was to determine whether Rifampicin dose impact infection outcomes in PJI due to S...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonnelier, M., Bouras, A., Joseph, C., Samad, Y. El, Brunschweiler, B., Schmit, J.-L., Mabille, C., Lanoix, J-P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881571/
https://www.ncbi.nlm.nih.gov/pubmed/33579208
http://dx.doi.org/10.1186/s12879-021-05832-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881571/
https://www.ncbi.nlm.nih.gov/pubmed/33579208
http://dx.doi.org/10.1186/s12879-021-05832-2

Ejemplares similares